RPG LIFE SCIENCES LTD
RPGLIFE · Pharma · NSE
₹2,011
Current Market Price
Fair Value (DCF)
₹1,279
Margin of Safety
-36.4%
Updated 1h ago
YieldIQ Score
50/100
Piotroski F-Score
6/9
Economic Moat
Wide
Confidence
72%
ROE
—
Debt/Equity
0.00
WACC
9.7%
Market Cap
₹3,327 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
43.4%
Return on capital employed
EV / EBITDA
21.5×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
376.6×
EBIT covers interest
Current Ratio
3.88×
Short-term liquidity
Asset Turnover
0.98×
Revenue per ₹ of assets
Revenue CAGR (3Y)
14.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹2,011.4
Bear case
₹678.21
MoS -196.6%
Base case
₹1,279.35
MoS -57.2%
Bull case
₹1,579.95
MoS -27.3%
Ratio Trends
RPGLIFE · last 9 annual periods
ROE
34.5%
ROCE
48.1%
Operating Margin
—
Debt / Equity
0.00×
PE
111.9×
EV / EBITDA
10.5×
Historical Financials
RPGLIFE · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹389 Cr | ₹440 Cr | ₹118 Cr | ₹127 Cr | ₹648 Cr | +13.6% |
| EBITDA | — | ₹89.3 Cr | ₹107 Cr | ₹135 Cr | ₹255 Cr | +30.0% |
| EBIT | ₹54.4 Cr | ₹73.7 Cr | ₹13.9 Cr | ₹17.9 Cr | — | -24.3% |
| PAT | ₹40.0 Cr | ₹51.5 Cr | ₹10.3 Cr | ₹13.2 Cr | ₹183 Cr | +46.3% |
| EPS (diluted) | ₹24.19 | ₹31.13 | ₹6.26 | ₹8.01 | — | -24.1% |
| CFO | ₹58.3 Cr | ₹64.8 Cr | ₹90.8 Cr | ₹94.4 Cr | ₹77.9 Cr | +7.5% |
| CapEx | — | — | — | — | ₹-36.0 Cr | — |
| FCF | — | — | — | — | ₹41.8 Cr | +0.0% |
| Total Assets | — | ₹345 Cr | ₹419 Cr | ₹513 Cr | ₹658 Cr | +17.5% |
| Total Debt | — | — | ₹0.0 Cr | ₹0.0 Cr | — | — |
| Shareholders' Equity | — | — | ₹308 Cr | ₹375 Cr | ₹531 Cr | +14.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
RPGLIFE vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| AARTIDRUGS AARTIDRUGS | — | — | Pending | 12.3% | — |
| GUJTHEM GUJTHEM | — | — | Pending | 19.6% | — |
| GUFICBIO GUFICBIO | — | — | Pending | 11.6% | — |
| ORCHPHARMA ORCHPHARMA | — | — | Pending | 7.9% | — |
| BLISSGVS BLISSGVS | — | — | Pending | 7.7% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for RPGLIFE in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. RPG LIFE SCIENCES LTD (RPGLIFE.NS) trades at 2011.40 vs a model fair value of 1279.35, a gap of -36.4%. Piotroski F-score: 6/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of RPGLIFE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for RPGLIFE →
Compare
Head-to-head with peers
Compare RPGLIFE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse RPGLIFENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.